Published in Blood Weekly, April 1st, 2010
"However those studies employed antibodies with questionable specificity and the significance of the observations are controversial. In order to accurately determine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.